Survodutide – 6mg

Survodutide (also known as BI 456906) is a novel dual agonist peptide that targets both the GLP-1 (glucagon-like peptide-1) receptor and the glucagon receptor. By combining these pathways, Survodutide is being researched for its ability to reduce body weight, enhance energy expenditure, and improve metabolic health. Its long-acting profile supports once-weekly dosing in experimental models.